Dopamine, Parkinson's disease, and volition

被引：2
|
作者：
Horvitz, JC [1 ]
机构：
[1] Columbia Univ, Dept Psychol, New York, NY 10027 USA
来源：
BEHAVIORAL AND BRAIN SCIENCES | 2002年 / 25卷 / 05期
关键词：
D O I：
10.1017/S0140525X02300104
中图分类号：
B84 [心理学];
学科分类号：
04 ; 0402 ;
摘要：
Disruptions in dopamine transmission within the basal ganglia (BG) produce deficits in voluntary actions, that is, in the interface between cortically-generated goal representation and BG-mediated response selection. Under conditions of dopamine loss in humans and other annuals, responses are impaired when they require internal generation, but are relatively intact when elicited by external stimuli.
引用
收藏
页码：586 / +
页数：7
相关论文
共 50 条
  • [21] Dopamine/glutamate interactions in Parkinson's disease
    Lange, KW
    Kornhuber, J
    Riederer, P
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04): : 393 - 400
  • [22] Dopamine neurotransmission, Parkinson's disease and SPET
    Costa, DC
    Lees, AJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2002, 29 (01) : 163 - 163
  • [23] Choosing dopamine agonists in Parkinson's disease
    Jankovic, J
    Tan, EK
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (05) : 247 - 253
  • [24] Dopamine agonists in the treatment of Parkinson's disease
    Bracco, F
    Delibori, D
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 201 - 207
  • [25] The dopamine transporter: Importance in Parkinson's disease
    Nutt, JG
    Carter, JH
    Sexton, GJ
    ANNALS OF NEUROLOGY, 2004, 55 (06) : 766 - 773
  • [26] Dopamine and Parkinson's disease: is the killer in the house?
    M-F Chesselet
    Molecular Psychiatry, 2003, 8 : 369 - 370
  • [27] Dopamine agonist monotherapy in Parkinson's disease
    Clarke, CE
    Guttman, M
    LANCET, 2002, 360 (9347): : 1767 - 1769
  • [28] Comparing dopamine agonists in Parkinson's disease
    Bonuccelli, U
    CURRENT OPINION IN NEUROLOGY, 2003, 16 : S13 - S19
  • [29] Dopamine agonists and sleep in Parkinson's disease
    Cantor, CR
    Stern, MB
    NEUROLOGY, 2002, 58 (04) : S71 - S78
  • [30] Intrathecal and intracerebroventricular dopamine for Parkinson's disease
    Abraham, Mickey E.
    Gold, Justin
    Dondapati, Akhil
    Gendreau, Julian
    Mammis, Antonios
    Herschman, Yehuda
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 200
12345